Orodispersible tablet containing Estetrol
The invention provides an orodispersible solid pharmaceutical dosage unit having a weight between 30 and 1,000 mg, said dosage unit containing at least 100 μg of an estetrol component selected from estetrol, estetrol esters and combinations thereof; wherein the solid dosage unit can be obtained by a process that comprises: providing a loading liquid comprising organic solvent; estetrol component and optionally one or more other pharmaceutically acceptable ingredients; mixing 1 part by weight of the loading liquid with 0.5-20 parts by weight of carrier particles to produce wet particles; removing organic solvent from the wet particles to produce loaded particles; optionally mixing the loaded particles with one or more tabletting excipients; and forming the loaded particles or the mixture of the loaded particles and the one or more tabletting excipients into a solid dosage unit. The solid dosage unit is easy to manufacture and perfectly suited for sublingual, buccal or sublabial administration.
1. A process of making an orodispersible solid pharmaceutical dosage unit having a weight between 30 and 1,000 mg and containing at least 300 μg of an estetrol component selected from one or more of estetrol and estetrol esters, comprising:
providing carrier particles having a volume weighted average particle size of 10 μm to 400 μm;
providing a loading liquid comprising an organic solvent in an amount of at least 50 wt. % selected from one or more of methanol, ethanol, isopropanol, and acetone; the estetrol component in an amount of 1-50 wt. %, and one or more other pharmaceutically acceptable ingredients in an amount of 0-49 wt. %;
mixing 1 part by weight of the loading liquid with 0.5-20 parts by weight of the carrier particles to produce wet particles;
removing the organic solvent from the wet particles to produce loaded particles;
optionally, mixing the loaded particles with one or more tabletting excipients to produce a mixture; and
forming the loaded particles or the mixture into a solid dosage unit having a weight between 30 and 1,000 mg and containing at least 300 μg of the estetrol component.
2. The process according to claim 1 , wherein the carrier particles contain a water-soluble carbohydrate in an amount of at least 30 wt. %, selected from one or more of monosaccharides, disaccharides, trisaccharides, and C 4 -C 12 sugar alcohols.
3. The process according to claim 2 , wherein the carrier particles contain the water-soluble carbohydrate in an amount of at least 50 wt. %.
4. The process according to claim 2 , wherein the water-soluble carbohydrate is selected from one or more of maltose, fructose, sucrose, lactose, glucose, galactose, trehalose, xylitol, sorbitol, erythritol, maltitol, and mannitol.
5. The process according to claim 1 , wherein the carrier particles contain mannitol in an amount of at least 20 wt. %.
6. The process according to claim 1 , wherein the carrier particles contain lactose in an amount of at least 10 wt. %.
7. The process according to claim 1 , wherein more than 90 wt. % of the estetrol component in the loading liquid is dissolved when the loading liquid is mixed with the carrier particles.
8. The process according to claim 1 , wherein the estetrol component is present in the loading liquid in an amount of 2-40 wt. %.
9. The process according to claim 1 , wherein the loading liquid contains a binder in an amount of 0.5-40 wt. % selected from one or more of cellulose derivatives and polyethylene glycol.
10. The process according to claim 9 , wherein the binder is ethylcellulose.
11. The process according to claim 1 , wherein the wet particles are produced by combining the loading liquid and the carrier particles in a high shear granulator, a low shear granulator, or a fluidized bed granulator.
12. The process according to claim 1 , wherein the organic solvent is removed from the wet particles in a fluidized bed granulator.
13. The process according to claim 1 , wherein the loading liquid contains at least 60 wt. % ethanol.
14. The process according to claim 1 , wherein the wet particles are prepared by mixing the loading liquid with the carrier particles in a weight ratio that is in the range of 1:0.8 to 1:12.
15. The process according to claim 1 , wherein the loaded particles have a volume mean diameter in a range of from 100 to 4,000 μm.
16. The process according to claim 1 , wherein the tabletting excipients contain a disintegrating agent in an amount of 0-20% by weight of the dosage unit, selected from one or more of modified starches, crosslinked polyvinylpyrrolidone, and crosslinked carmellose.
17. The process according to claim 1 , wherein the one or more tabletting excipients comprise at least 30% by weight of the dosage unit of one or more selected from lactose, mannitol, xylitol, microcrystalline cellulose, starch, croscarmellose sodium, and polyvinyl pyrrolidone.
18. The process according to claim 1 , wherein the dosage unit is formed by direct compression or compression molding.
19. The process according to claim 1 , wherein the dosage unit has a weight between 40 and 500 mg.
20. The process according to claim 1 , wherein the dosage unit contains 0.3-100 mg of the estetrol component.
21. The process according to claim 1 , wherein the estetrol component is estetrol.